Published in Prenat Diagn on January 01, 2011
MR-based morphometry of the posterior fossa in fetuses with neural tube defects of the spine. PLoS One (2014) 0.80
Approach to the sonographic evaluation of fetal ventriculomegaly at 11 to 14 weeks gestation. BMC Pregnancy Childbirth (2016) 0.75
Detection of neural tube defect in the first and second trimester of pregnancy by ultrasound in Imam Hospital, Ahwaz between December 2008-2010. Iran J Reprod Med (2012) 0.75
Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery. Childs Nerv Syst (2017) 0.75
Fetal diffusion tensor quantification of brainstem pathology in Chiari II malformation. Eur Radiol (2015) 0.75
Sonographic detection of open spina bifida in the first trimester: review of the literature. Childs Nerv Syst (2017) 0.75
Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med (2007) 5.36
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med (2007) 3.34
Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet (2004) 3.00
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med (2016) 2.73
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem (2006) 2.41
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One (2011) 2.29
Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol (2012) 2.17
An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol (2005) 1.96
Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem (2006) 1.85
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet (2003) 1.84
Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol (2007) 1.84
Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem (2009) 1.76
First-trimester prediction of hypertensive disorders in pregnancy. Hypertension (2009) 1.73
MR obstetric pelvimetry: effect of birthing position on pelvic bony dimensions. AJR Am J Roentgenol (2002) 1.54
Maternal and foetal angiogenic imbalance in congenital heart defects. Eur Heart J (2013) 1.50
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn (2011) 1.48
Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol (2006) 1.47
Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies. Metabolism (2013) 1.46
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J (2002) 1.42
Maternal circulating endothelial progenitor cells in normal singleton and twin pregnancy. Am J Obstet Gynecol (2008) 1.42
Maternal serum progesterone-induced blocking factor at 11-13 weeks' gestation in spontaneous early preterm delivery. Fetal Diagn Ther (2011) 1.39
The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol (2004) 1.34
Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn (2008) 1.30
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study. BMJ (2006) 1.22
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem (2009) 1.18
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn (2010) 1.17
Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol (2006) 1.17
Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol (2005) 1.11
Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther (2012) 1.11
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors. Fetal Diagn Ther (2012) 1.11
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn (2005) 1.09
Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn (2011) 1.08
Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG (2005) 1.07
Maternal wave reflections and arterial stiffness in normal pregnancy as assessed by applanation tonometry. Hypertension (2008) 1.05
First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol (2008) 1.03
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. Am J Obstet Gynecol (2006) 1.01
Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Heart Circ Physiol (2009) 1.00
Normal range of maternal serum vitamin d at 11-13 weeks' gestation. Fetal Diagn Ther (2011) 1.00
Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol (2008) 1.00
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid (2010) 0.99
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod (2008) 0.99
Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther (2012) 0.98
Some thoughts on the true value of ultrasound. Ultrasound Obstet Gynecol (2007) 0.97
Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn (2009) 0.96
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn (2011) 0.95
Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One (2010) 0.94
The influence of medical and psychological interventions on women's distress after miscarriage. J Psychosom Res (2007) 0.94
Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol (2005) 0.94
Predictors of necrotizing enterocolitis in preterm growth-restricted neonates. Am J Obstet Gynecol (2008) 0.93
Lung volumes in fetuses with congenital diaphragmatic hernia: comparison of 3D US and MR imaging assessments. Radiology (2007) 0.93
Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension (2008) 0.92
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn (2003) 0.92
Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther (2013) 0.92
Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins. Am J Obstet Gynecol (2006) 0.92
Current outcome of antenatally diagnosed exomphalos: an 11 year review. J Pediatr Surg (2006) 0.92
The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. Am J Obstet Gynecol (2010) 0.91
Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther (2010) 0.91
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn (2009) 0.91
ADAM12-s in coelomic fluid and maternal serum in early pregnancy. Prenat Diagn (2006) 0.90
Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length. Am J Perinatol (2006) 0.90
Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation. Fetal Diagn Ther (2014) 0.90
Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks. Prenat Diagn (2011) 0.90
Fetal bilateral renal agenesis, phocomelia, and single umbilical artery associated with cocaine abuse in early pregnancy. Birth Defects Res A Clin Mol Teratol (2003) 0.90
Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat Diagn (2010) 0.90
First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn (2014) 0.89
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn (2011) 0.89
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG (2002) 0.89
MRI of cardiac rhabdomyoma in the fetus. Eur Radiol (2003) 0.89
Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn (2008) 0.89
Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome. PLoS One (2010) 0.89
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol (2006) 0.89
Fetal thrombocytopenia secondary to parvovirus infection. Am J Obstet Gynecol (2007) 0.89
Frontomaxillary facial angle in fetuses with trisomy 21 at 11-13(6) weeks. Am J Obstet Gynecol (2007) 0.89
Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn (2010) 0.89
Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Am J Obstet Gynecol (2009) 0.89
Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn (2007) 0.89
A competing risks model in early screening for preeclampsia. Fetal Diagn Ther (2012) 0.88
Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn (2003) 0.88
Maternal thyroid function at 11-13 weeks of gestation. Fetal Diagn Ther (2010) 0.87
Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstet Gynecol (2008) 0.87
First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol (2009) 0.87
Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol (2007) 0.87
Body mass index at 11-13 weeks' gestation and pregnancy complications. Fetal Diagn Ther (2011) 0.87
First-trimester maternal serum vitamin D and mode of delivery. Br J Nutr (2012) 0.87
Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11-13 weeks. Hypertens Pregnancy (2010) 0.87
Ultrasonographic prediction of early miscarriage. Hum Reprod (2011) 0.87
Prenatal diagnosis of trisomy 1q21-qter: case report and review of literature. Am J Med Genet A (2005) 0.86
Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. Fetal Diagn Ther (2011) 0.86
Nasal bone assessment in fetuses with trisomy 21 at 16-24 weeks of gestation by three-dimensional ultrasound. Prenat Diagn (2012) 0.86
Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol (2002) 0.86
Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. Clin Chem (2005) 0.86
Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol (2011) 0.86
Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn (2010) 0.86
Comparison of protocols for extracting circulating DNA and RNA from maternal plasma. Clin Chem (2005) 0.85
Prevalence and outcome of absence of ductus venosus at 11(+0) to 13(+6) weeks. Fetal Diagn Ther (2011) 0.85
Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery. Obstet Gynecol (2011) 0.85
Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy. Eur J Echocardiogr (2007) 0.85
Collaborative study on 3-dimensional sonography for the prenatal diagnosis of central nervous system defects. J Ultrasound Med (2011) 0.85